nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—CYP2C9—Trimethadione—epilepsy syndrome	0.0723	0.17	CbGbCtD
Treprostinil—CYP2C9—Fosphenytoin—epilepsy syndrome	0.068	0.16	CbGbCtD
Treprostinil—CYP2C9—Carbamazepine—epilepsy syndrome	0.0488	0.115	CbGbCtD
Treprostinil—CYP2C9—Primidone—epilepsy syndrome	0.0456	0.107	CbGbCtD
Treprostinil—CYP2C9—Phenytoin—epilepsy syndrome	0.0438	0.103	CbGbCtD
Treprostinil—CYP2C9—Propofol—epilepsy syndrome	0.0408	0.0962	CbGbCtD
Treprostinil—CYP2C9—Phenobarbital—epilepsy syndrome	0.039	0.0919	CbGbCtD
Treprostinil—CYP2C9—Diazepam—epilepsy syndrome	0.037	0.0872	CbGbCtD
Treprostinil—CYP2C9—Valproic Acid—epilepsy syndrome	0.0292	0.0687	CbGbCtD
Treprostinil—PTGIR—hindbrain—epilepsy syndrome	0.00552	0.0929	CbGeAlD
Treprostinil—P2RY12—forebrain—epilepsy syndrome	0.00479	0.0806	CbGeAlD
Treprostinil—PPARD—forebrain—epilepsy syndrome	0.00398	0.0669	CbGeAlD
Treprostinil—PPARD—telencephalon—epilepsy syndrome	0.00366	0.0615	CbGeAlD
Treprostinil—PTGIR—brainstem—epilepsy syndrome	0.00317	0.0533	CbGeAlD
Treprostinil—PTGIR—forebrain—epilepsy syndrome	0.00306	0.0514	CbGeAlD
Treprostinil—PTGIR—telencephalon—epilepsy syndrome	0.00281	0.0473	CbGeAlD
Treprostinil—P2RY12—head—epilepsy syndrome	0.00274	0.0461	CbGeAlD
Treprostinil—PPARD—midbrain—epilepsy syndrome	0.00263	0.0442	CbGeAlD
Treprostinil—P2RY12—nervous system—epilepsy syndrome	0.0026	0.0437	CbGeAlD
Treprostinil—P2RY12—central nervous system—epilepsy syndrome	0.0025	0.0421	CbGeAlD
Treprostinil—PPARD—head—epilepsy syndrome	0.00228	0.0383	CbGeAlD
Treprostinil—PPARD—nervous system—epilepsy syndrome	0.00216	0.0363	CbGeAlD
Treprostinil—PPARD—central nervous system—epilepsy syndrome	0.00208	0.035	CbGeAlD
Treprostinil—PPARD—cerebellum—epilepsy syndrome	0.00203	0.0342	CbGeAlD
Treprostinil—P2RY12—brain—epilepsy syndrome	0.00199	0.0334	CbGeAlD
Treprostinil—PTGIR—spinal cord—epilepsy syndrome	0.00197	0.0331	CbGeAlD
Treprostinil—PTGIR—head—epilepsy syndrome	0.00175	0.0294	CbGeAlD
Treprostinil—PTGIR—nervous system—epilepsy syndrome	0.00166	0.0279	CbGeAlD
Treprostinil—PPARD—brain—epilepsy syndrome	0.00165	0.0278	CbGeAlD
Treprostinil—PTGIR—central nervous system—epilepsy syndrome	0.0016	0.0269	CbGeAlD
Treprostinil—PTGIR—cerebellum—epilepsy syndrome	0.00156	0.0263	CbGeAlD
Treprostinil—PTGIR—brain—epilepsy syndrome	0.00127	0.0213	CbGeAlD
Treprostinil—Rash—Levetiracetam—epilepsy syndrome	0.000161	0.000468	CcSEcCtD
Treprostinil—Anaemia—Pregabalin—epilepsy syndrome	0.000161	0.000468	CcSEcCtD
Treprostinil—Dermatitis—Levetiracetam—epilepsy syndrome	0.000161	0.000468	CcSEcCtD
Treprostinil—Asthenia—Zonisamide—epilepsy syndrome	0.000161	0.000467	CcSEcCtD
Treprostinil—Headache—Levetiracetam—epilepsy syndrome	0.00016	0.000465	CcSEcCtD
Treprostinil—Erythema—Gabapentin—epilepsy syndrome	0.00016	0.000464	CcSEcCtD
Treprostinil—Angioedema—Pregabalin—epilepsy syndrome	0.000159	0.000463	CcSEcCtD
Treprostinil—Dizziness—Vigabatrin—epilepsy syndrome	0.000159	0.000462	CcSEcCtD
Treprostinil—Pruritus—Zonisamide—epilepsy syndrome	0.000158	0.000461	CcSEcCtD
Treprostinil—Oedema—Valproic Acid—epilepsy syndrome	0.000157	0.000457	CcSEcCtD
Treprostinil—Bradycardia—Topiramate—epilepsy syndrome	0.000157	0.000457	CcSEcCtD
Treprostinil—Malaise—Pregabalin—epilepsy syndrome	0.000157	0.000457	CcSEcCtD
Treprostinil—Nausea—Propofol—epilepsy syndrome	0.000157	0.000456	CcSEcCtD
Treprostinil—Tension—Gabapentin—epilepsy syndrome	0.000157	0.000456	CcSEcCtD
Treprostinil—Vomiting—Fosphenytoin—epilepsy syndrome	0.000157	0.000455	CcSEcCtD
Treprostinil—Diarrhoea—Felbamate—epilepsy syndrome	0.000156	0.000455	CcSEcCtD
Treprostinil—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000156	0.000455	CcSEcCtD
Treprostinil—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000156	0.000455	CcSEcCtD
Treprostinil—Dizziness—Diazepam—epilepsy syndrome	0.000156	0.000455	CcSEcCtD
Treprostinil—Infection—Valproic Acid—epilepsy syndrome	0.000156	0.000454	CcSEcCtD
Treprostinil—Syncope—Pregabalin—epilepsy syndrome	0.000156	0.000454	CcSEcCtD
Treprostinil—Rash—Fosphenytoin—epilepsy syndrome	0.000155	0.000452	CcSEcCtD
Treprostinil—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000155	0.000451	CcSEcCtD
Treprostinil—Haemoglobin—Topiramate—epilepsy syndrome	0.000155	0.000451	CcSEcCtD
Treprostinil—Nervousness—Gabapentin—epilepsy syndrome	0.000155	0.000451	CcSEcCtD
Treprostinil—Asthenia—Clonazepam—epilepsy syndrome	0.000155	0.00045	CcSEcCtD
Treprostinil—Rhinitis—Topiramate—epilepsy syndrome	0.000155	0.00045	CcSEcCtD
Treprostinil—Back pain—Gabapentin—epilepsy syndrome	0.000154	0.000449	CcSEcCtD
Treprostinil—Headache—Fosphenytoin—epilepsy syndrome	0.000154	0.000449	CcSEcCtD
Treprostinil—Haemorrhage—Topiramate—epilepsy syndrome	0.000154	0.000449	CcSEcCtD
Treprostinil—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000154	0.000447	CcSEcCtD
Treprostinil—Palpitations—Pregabalin—epilepsy syndrome	0.000154	0.000447	CcSEcCtD
Treprostinil—Asthenia—Phenytoin—epilepsy syndrome	0.000154	0.000447	CcSEcCtD
Treprostinil—Nausea—Midazolam—epilepsy syndrome	0.000153	0.000446	CcSEcCtD
Treprostinil—Muscle spasms—Gabapentin—epilepsy syndrome	0.000153	0.000446	CcSEcCtD
Treprostinil—Tachycardia—Valproic Acid—epilepsy syndrome	0.000153	0.000446	CcSEcCtD
Treprostinil—Diarrhoea—Zonisamide—epilepsy syndrome	0.000153	0.000446	CcSEcCtD
Treprostinil—Pharyngitis—Topiramate—epilepsy syndrome	0.000153	0.000445	CcSEcCtD
Treprostinil—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000153	0.000445	CcSEcCtD
Treprostinil—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000153	0.000445	CcSEcCtD
Treprostinil—Pruritus—Clonazepam—epilepsy syndrome	0.000153	0.000444	CcSEcCtD
Treprostinil—Vomiting—Vigabatrin—epilepsy syndrome	0.000153	0.000444	CcSEcCtD
Treprostinil—Oedema peripheral—Topiramate—epilepsy syndrome	0.000152	0.000442	CcSEcCtD
Treprostinil—Cough—Pregabalin—epilepsy syndrome	0.000152	0.000442	CcSEcCtD
Treprostinil—Pruritus—Phenytoin—epilepsy syndrome	0.000152	0.000441	CcSEcCtD
Treprostinil—Nausea—Levetiracetam—epilepsy syndrome	0.000152	0.000441	CcSEcCtD
Treprostinil—Rash—Vigabatrin—epilepsy syndrome	0.000151	0.00044	CcSEcCtD
Treprostinil—Dizziness—Felbamate—epilepsy syndrome	0.000151	0.00044	CcSEcCtD
Treprostinil—Dermatitis—Vigabatrin—epilepsy syndrome	0.000151	0.00044	CcSEcCtD
Treprostinil—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000151	0.000439	CcSEcCtD
Treprostinil—Headache—Vigabatrin—epilepsy syndrome	0.00015	0.000437	CcSEcCtD
Treprostinil—Vomiting—Diazepam—epilepsy syndrome	0.00015	0.000437	CcSEcCtD
Treprostinil—Anorexia—Valproic Acid—epilepsy syndrome	0.00015	0.000436	CcSEcCtD
Treprostinil—Rash—Diazepam—epilepsy syndrome	0.000149	0.000433	CcSEcCtD
Treprostinil—Dermatitis—Diazepam—epilepsy syndrome	0.000149	0.000433	CcSEcCtD
Treprostinil—Arthralgia—Pregabalin—epilepsy syndrome	0.000148	0.000431	CcSEcCtD
Treprostinil—Chest pain—Pregabalin—epilepsy syndrome	0.000148	0.000431	CcSEcCtD
Treprostinil—Myalgia—Pregabalin—epilepsy syndrome	0.000148	0.000431	CcSEcCtD
Treprostinil—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000148	0.000431	CcSEcCtD
Treprostinil—Dizziness—Zonisamide—epilepsy syndrome	0.000148	0.000431	CcSEcCtD
Treprostinil—Headache—Diazepam—epilepsy syndrome	0.000148	0.000431	CcSEcCtD
Treprostinil—Anxiety—Pregabalin—epilepsy syndrome	0.000148	0.00043	CcSEcCtD
Treprostinil—Diarrhoea—Clonazepam—epilepsy syndrome	0.000148	0.000429	CcSEcCtD
Treprostinil—Anaemia—Gabapentin—epilepsy syndrome	0.000147	0.000429	CcSEcCtD
Treprostinil—Hypotension—Valproic Acid—epilepsy syndrome	0.000147	0.000427	CcSEcCtD
Treprostinil—Asthenia—Carbamazepine—epilepsy syndrome	0.000147	0.000427	CcSEcCtD
Treprostinil—Diarrhoea—Phenytoin—epilepsy syndrome	0.000147	0.000427	CcSEcCtD
Treprostinil—Discomfort—Pregabalin—epilepsy syndrome	0.000146	0.000426	CcSEcCtD
Treprostinil—Nausea—Fosphenytoin—epilepsy syndrome	0.000146	0.000425	CcSEcCtD
Treprostinil—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000146	0.000424	CcSEcCtD
Treprostinil—Angioedema—Gabapentin—epilepsy syndrome	0.000146	0.000424	CcSEcCtD
Treprostinil—Vomiting—Felbamate—epilepsy syndrome	0.000145	0.000423	CcSEcCtD
Treprostinil—Pruritus—Carbamazepine—epilepsy syndrome	0.000145	0.000421	CcSEcCtD
Treprostinil—Rash—Felbamate—epilepsy syndrome	0.000144	0.000419	CcSEcCtD
Treprostinil—Dermatitis—Felbamate—epilepsy syndrome	0.000144	0.000419	CcSEcCtD
Treprostinil—Malaise—Gabapentin—epilepsy syndrome	0.000144	0.000419	CcSEcCtD
Treprostinil—Headache—Felbamate—epilepsy syndrome	0.000143	0.000417	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000143	0.000416	CcSEcCtD
Treprostinil—Flushing—Topiramate—epilepsy syndrome	0.000143	0.000416	CcSEcCtD
Treprostinil—Syncope—Gabapentin—epilepsy syndrome	0.000143	0.000416	CcSEcCtD
Treprostinil—Dizziness—Clonazepam—epilepsy syndrome	0.000143	0.000415	CcSEcCtD
Treprostinil—Nausea—Vigabatrin—epilepsy syndrome	0.000143	0.000415	CcSEcCtD
Treprostinil—Vomiting—Zonisamide—epilepsy syndrome	0.000142	0.000414	CcSEcCtD
Treprostinil—Insomnia—Valproic Acid—epilepsy syndrome	0.000142	0.000413	CcSEcCtD
Treprostinil—Oedema—Pregabalin—epilepsy syndrome	0.000142	0.000413	CcSEcCtD
Treprostinil—Asthenia—Lamotrigine—epilepsy syndrome	0.000142	0.000413	CcSEcCtD
Treprostinil—Dizziness—Phenytoin—epilepsy syndrome	0.000142	0.000412	CcSEcCtD
Treprostinil—Rash—Zonisamide—epilepsy syndrome	0.000141	0.000411	CcSEcCtD
Treprostinil—Infection—Pregabalin—epilepsy syndrome	0.000141	0.00041	CcSEcCtD
Treprostinil—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000141	0.00041	CcSEcCtD
Treprostinil—Palpitations—Gabapentin—epilepsy syndrome	0.000141	0.00041	CcSEcCtD
Treprostinil—Dermatitis—Zonisamide—epilepsy syndrome	0.000141	0.00041	CcSEcCtD
Treprostinil—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000141	0.00041	CcSEcCtD
Treprostinil—Nausea—Diazepam—epilepsy syndrome	0.00014	0.000408	CcSEcCtD
Treprostinil—Loss of consciousness—Gabapentin—epilepsy syndrome	0.00014	0.000408	CcSEcCtD
Treprostinil—Headache—Zonisamide—epilepsy syndrome	0.00014	0.000408	CcSEcCtD
Treprostinil—Dyspnoea—Valproic Acid—epilepsy syndrome	0.00014	0.000407	CcSEcCtD
Treprostinil—Diarrhoea—Carbamazepine—epilepsy syndrome	0.00014	0.000407	CcSEcCtD
Treprostinil—Pruritus—Lamotrigine—epilepsy syndrome	0.00014	0.000407	CcSEcCtD
Treprostinil—Shock—Pregabalin—epilepsy syndrome	0.00014	0.000406	CcSEcCtD
Treprostinil—Cough—Gabapentin—epilepsy syndrome	0.000139	0.000405	CcSEcCtD
Treprostinil—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000139	0.000405	CcSEcCtD
Treprostinil—Tachycardia—Pregabalin—epilepsy syndrome	0.000139	0.000403	CcSEcCtD
Treprostinil—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000138	0.000402	CcSEcCtD
Treprostinil—Vomiting—Clonazepam—epilepsy syndrome	0.000137	0.000399	CcSEcCtD
Treprostinil—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000137	0.000397	CcSEcCtD
Treprostinil—Vomiting—Phenytoin—epilepsy syndrome	0.000136	0.000396	CcSEcCtD
Treprostinil—Rash—Clonazepam—epilepsy syndrome	0.000136	0.000396	CcSEcCtD
Treprostinil—Dermatitis—Clonazepam—epilepsy syndrome	0.000136	0.000395	CcSEcCtD
Treprostinil—Arthralgia—Gabapentin—epilepsy syndrome	0.000136	0.000395	CcSEcCtD
Treprostinil—Myalgia—Gabapentin—epilepsy syndrome	0.000136	0.000395	CcSEcCtD
Treprostinil—Chest pain—Gabapentin—epilepsy syndrome	0.000136	0.000395	CcSEcCtD
Treprostinil—Nausea—Felbamate—epilepsy syndrome	0.000136	0.000395	CcSEcCtD
Treprostinil—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000136	0.000394	CcSEcCtD
Treprostinil—Fatigue—Valproic Acid—epilepsy syndrome	0.000135	0.000394	CcSEcCtD
Treprostinil—Anxiety—Gabapentin—epilepsy syndrome	0.000135	0.000394	CcSEcCtD
Treprostinil—Anorexia—Pregabalin—epilepsy syndrome	0.000135	0.000394	CcSEcCtD
Treprostinil—Dizziness—Carbamazepine—epilepsy syndrome	0.000135	0.000394	CcSEcCtD
Treprostinil—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000135	0.000394	CcSEcCtD
Treprostinil—Headache—Clonazepam—epilepsy syndrome	0.000135	0.000393	CcSEcCtD
Treprostinil—Rash—Phenytoin—epilepsy syndrome	0.000135	0.000393	CcSEcCtD
Treprostinil—Dermatitis—Phenytoin—epilepsy syndrome	0.000135	0.000393	CcSEcCtD
Treprostinil—Rash—Oxcarbazepine—epilepsy syndrome	0.000134	0.000391	CcSEcCtD
Treprostinil—Pain—Valproic Acid—epilepsy syndrome	0.000134	0.000391	CcSEcCtD
Treprostinil—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000134	0.000391	CcSEcCtD
Treprostinil—Headache—Phenytoin—epilepsy syndrome	0.000134	0.000391	CcSEcCtD
Treprostinil—Erythema—Topiramate—epilepsy syndrome	0.000134	0.000391	CcSEcCtD
Treprostinil—Discomfort—Gabapentin—epilepsy syndrome	0.000134	0.00039	CcSEcCtD
Treprostinil—Headache—Oxcarbazepine—epilepsy syndrome	0.000134	0.000388	CcSEcCtD
Treprostinil—Nausea—Zonisamide—epilepsy syndrome	0.000133	0.000387	CcSEcCtD
Treprostinil—Hypotension—Pregabalin—epilepsy syndrome	0.000133	0.000386	CcSEcCtD
Treprostinil—Tension—Topiramate—epilepsy syndrome	0.000132	0.000383	CcSEcCtD
Treprostinil—Dizziness—Lamotrigine—epilepsy syndrome	0.000131	0.00038	CcSEcCtD
Treprostinil—Nervousness—Topiramate—epilepsy syndrome	0.00013	0.000379	CcSEcCtD
Treprostinil—Oedema—Gabapentin—epilepsy syndrome	0.00013	0.000379	CcSEcCtD
Treprostinil—Vomiting—Carbamazepine—epilepsy syndrome	0.00013	0.000378	CcSEcCtD
Treprostinil—Back pain—Topiramate—epilepsy syndrome	0.00013	0.000378	CcSEcCtD
Treprostinil—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000129	0.000377	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000129	0.000376	CcSEcCtD
Treprostinil—Infection—Gabapentin—epilepsy syndrome	0.000129	0.000376	CcSEcCtD
Treprostinil—Muscle spasms—Topiramate—epilepsy syndrome	0.000129	0.000375	CcSEcCtD
Treprostinil—Rash—Carbamazepine—epilepsy syndrome	0.000129	0.000375	CcSEcCtD
Treprostinil—Dermatitis—Carbamazepine—epilepsy syndrome	0.000129	0.000375	CcSEcCtD
Treprostinil—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000128	0.000374	CcSEcCtD
Treprostinil—Insomnia—Pregabalin—epilepsy syndrome	0.000128	0.000374	CcSEcCtD
Treprostinil—Nausea—Clonazepam—epilepsy syndrome	0.000128	0.000373	CcSEcCtD
Treprostinil—Headache—Carbamazepine—epilepsy syndrome	0.000128	0.000373	CcSEcCtD
Treprostinil—Shock—Gabapentin—epilepsy syndrome	0.000128	0.000373	CcSEcCtD
Treprostinil—Paraesthesia—Pregabalin—epilepsy syndrome	0.000128	0.000371	CcSEcCtD
Treprostinil—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000127	0.000371	CcSEcCtD
Treprostinil—Nausea—Phenytoin—epilepsy syndrome	0.000127	0.00037	CcSEcCtD
Treprostinil—Tachycardia—Gabapentin—epilepsy syndrome	0.000127	0.00037	CcSEcCtD
Treprostinil—Dyspnoea—Pregabalin—epilepsy syndrome	0.000127	0.000368	CcSEcCtD
Treprostinil—Nausea—Oxcarbazepine—epilepsy syndrome	0.000127	0.000368	CcSEcCtD
Treprostinil—Vomiting—Lamotrigine—epilepsy syndrome	0.000126	0.000366	CcSEcCtD
Treprostinil—Rash—Lamotrigine—epilepsy syndrome	0.000125	0.000363	CcSEcCtD
Treprostinil—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000125	0.000362	CcSEcCtD
Treprostinil—Dermatitis—Lamotrigine—epilepsy syndrome	0.000125	0.000362	CcSEcCtD
Treprostinil—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000124	0.000361	CcSEcCtD
Treprostinil—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000124	0.000361	CcSEcCtD
Treprostinil—Anorexia—Gabapentin—epilepsy syndrome	0.000124	0.000361	CcSEcCtD
Treprostinil—Anaemia—Topiramate—epilepsy syndrome	0.000124	0.000361	CcSEcCtD
Treprostinil—Headache—Lamotrigine—epilepsy syndrome	0.000124	0.00036	CcSEcCtD
Treprostinil—Decreased appetite—Pregabalin—epilepsy syndrome	0.000123	0.000359	CcSEcCtD
Treprostinil—Fatigue—Pregabalin—epilepsy syndrome	0.000122	0.000356	CcSEcCtD
Treprostinil—Hypotension—Gabapentin—epilepsy syndrome	0.000122	0.000354	CcSEcCtD
Treprostinil—Nausea—Carbamazepine—epilepsy syndrome	0.000121	0.000353	CcSEcCtD
Treprostinil—Pain—Pregabalin—epilepsy syndrome	0.000121	0.000353	CcSEcCtD
Treprostinil—Malaise—Topiramate—epilepsy syndrome	0.000121	0.000352	CcSEcCtD
Treprostinil—Syncope—Topiramate—epilepsy syndrome	0.00012	0.00035	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000119	0.000345	CcSEcCtD
Treprostinil—Palpitations—Topiramate—epilepsy syndrome	0.000119	0.000345	CcSEcCtD
Treprostinil—Loss of consciousness—Topiramate—epilepsy syndrome	0.000118	0.000343	CcSEcCtD
Treprostinil—Insomnia—Gabapentin—epilepsy syndrome	0.000118	0.000343	CcSEcCtD
Treprostinil—Nausea—Lamotrigine—epilepsy syndrome	0.000117	0.000342	CcSEcCtD
Treprostinil—Cough—Topiramate—epilepsy syndrome	0.000117	0.000341	CcSEcCtD
Treprostinil—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000117	0.00034	CcSEcCtD
Treprostinil—Paraesthesia—Gabapentin—epilepsy syndrome	0.000117	0.00034	CcSEcCtD
Treprostinil—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000116	0.000338	CcSEcCtD
Treprostinil—Dyspnoea—Gabapentin—epilepsy syndrome	0.000116	0.000338	CcSEcCtD
Treprostinil—Dyspepsia—Gabapentin—epilepsy syndrome	0.000115	0.000334	CcSEcCtD
Treprostinil—Arthralgia—Topiramate—epilepsy syndrome	0.000114	0.000333	CcSEcCtD
Treprostinil—Myalgia—Topiramate—epilepsy syndrome	0.000114	0.000333	CcSEcCtD
Treprostinil—Chest pain—Topiramate—epilepsy syndrome	0.000114	0.000333	CcSEcCtD
Treprostinil—Anxiety—Topiramate—epilepsy syndrome	0.000114	0.000331	CcSEcCtD
Treprostinil—Decreased appetite—Gabapentin—epilepsy syndrome	0.000113	0.000329	CcSEcCtD
Treprostinil—Discomfort—Topiramate—epilepsy syndrome	0.000113	0.000329	CcSEcCtD
Treprostinil—Asthenia—Valproic Acid—epilepsy syndrome	0.000113	0.000328	CcSEcCtD
Treprostinil—Fatigue—Gabapentin—epilepsy syndrome	0.000112	0.000327	CcSEcCtD
Treprostinil—Abdominal pain—Pregabalin—epilepsy syndrome	0.000112	0.000327	CcSEcCtD
Treprostinil—Body temperature increased—Pregabalin—epilepsy syndrome	0.000112	0.000327	CcSEcCtD
Treprostinil—Pain—Gabapentin—epilepsy syndrome	0.000111	0.000324	CcSEcCtD
Treprostinil—Pruritus—Valproic Acid—epilepsy syndrome	0.000111	0.000323	CcSEcCtD
Treprostinil—Oedema—Topiramate—epilepsy syndrome	0.00011	0.000319	CcSEcCtD
Treprostinil—Infection—Topiramate—epilepsy syndrome	0.000109	0.000317	CcSEcCtD
Treprostinil—Shock—Topiramate—epilepsy syndrome	0.000108	0.000314	CcSEcCtD
Treprostinil—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000107	0.000313	CcSEcCtD
Treprostinil—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000107	0.000312	CcSEcCtD
Treprostinil—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000107	0.000312	CcSEcCtD
Treprostinil—Tachycardia—Topiramate—epilepsy syndrome	0.000107	0.000311	CcSEcCtD
Treprostinil—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000106	0.00031	CcSEcCtD
Treprostinil—Anorexia—Topiramate—epilepsy syndrome	0.000104	0.000304	CcSEcCtD
Treprostinil—Dizziness—Valproic Acid—epilepsy syndrome	0.000104	0.000302	CcSEcCtD
Treprostinil—Body temperature increased—Gabapentin—epilepsy syndrome	0.000103	0.0003	CcSEcCtD
Treprostinil—Abdominal pain—Gabapentin—epilepsy syndrome	0.000103	0.0003	CcSEcCtD
Treprostinil—Hypotension—Topiramate—epilepsy syndrome	0.000102	0.000298	CcSEcCtD
Treprostinil—Asthenia—Pregabalin—epilepsy syndrome	0.000102	0.000296	CcSEcCtD
Treprostinil—Pruritus—Pregabalin—epilepsy syndrome	0.0001	0.000292	CcSEcCtD
Treprostinil—Vomiting—Valproic Acid—epilepsy syndrome	9.99e-05	0.000291	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	9.98e-05	0.00029	CcSEcCtD
Treprostinil—Insomnia—Topiramate—epilepsy syndrome	9.91e-05	0.000288	CcSEcCtD
Treprostinil—Rash—Valproic Acid—epilepsy syndrome	9.9e-05	0.000288	CcSEcCtD
Treprostinil—Dermatitis—Valproic Acid—epilepsy syndrome	9.89e-05	0.000288	CcSEcCtD
Treprostinil—Headache—Valproic Acid—epilepsy syndrome	9.84e-05	0.000286	CcSEcCtD
Treprostinil—Paraesthesia—Topiramate—epilepsy syndrome	9.84e-05	0.000286	CcSEcCtD
Treprostinil—Dyspnoea—Topiramate—epilepsy syndrome	9.77e-05	0.000284	CcSEcCtD
Treprostinil—Diarrhoea—Pregabalin—epilepsy syndrome	9.72e-05	0.000283	CcSEcCtD
Treprostinil—Dyspepsia—Topiramate—epilepsy syndrome	9.64e-05	0.000281	CcSEcCtD
Treprostinil—Decreased appetite—Topiramate—epilepsy syndrome	9.52e-05	0.000277	CcSEcCtD
Treprostinil—Fatigue—Topiramate—epilepsy syndrome	9.44e-05	0.000275	CcSEcCtD
Treprostinil—Dizziness—Pregabalin—epilepsy syndrome	9.39e-05	0.000273	CcSEcCtD
Treprostinil—Pain—Topiramate—epilepsy syndrome	9.37e-05	0.000273	CcSEcCtD
Treprostinil—Asthenia—Gabapentin—epilepsy syndrome	9.34e-05	0.000272	CcSEcCtD
Treprostinil—Nausea—Valproic Acid—epilepsy syndrome	9.33e-05	0.000271	CcSEcCtD
Treprostinil—Pruritus—Gabapentin—epilepsy syndrome	9.21e-05	0.000268	CcSEcCtD
Treprostinil—Vomiting—Pregabalin—epilepsy syndrome	9.03e-05	0.000263	CcSEcCtD
Treprostinil—Feeling abnormal—Topiramate—epilepsy syndrome	9.03e-05	0.000263	CcSEcCtD
Treprostinil—Gastrointestinal pain—Topiramate—epilepsy syndrome	8.96e-05	0.000261	CcSEcCtD
Treprostinil—Rash—Pregabalin—epilepsy syndrome	8.95e-05	0.000261	CcSEcCtD
Treprostinil—Dermatitis—Pregabalin—epilepsy syndrome	8.94e-05	0.00026	CcSEcCtD
Treprostinil—Diarrhoea—Gabapentin—epilepsy syndrome	8.91e-05	0.000259	CcSEcCtD
Treprostinil—Headache—Pregabalin—epilepsy syndrome	8.9e-05	0.000259	CcSEcCtD
Treprostinil—Body temperature increased—Topiramate—epilepsy syndrome	8.66e-05	0.000252	CcSEcCtD
Treprostinil—Abdominal pain—Topiramate—epilepsy syndrome	8.66e-05	0.000252	CcSEcCtD
Treprostinil—Dizziness—Gabapentin—epilepsy syndrome	8.61e-05	0.000251	CcSEcCtD
Treprostinil—Nausea—Pregabalin—epilepsy syndrome	8.43e-05	0.000245	CcSEcCtD
Treprostinil—Vomiting—Gabapentin—epilepsy syndrome	8.28e-05	0.000241	CcSEcCtD
Treprostinil—Rash—Gabapentin—epilepsy syndrome	8.21e-05	0.000239	CcSEcCtD
Treprostinil—Dermatitis—Gabapentin—epilepsy syndrome	8.2e-05	0.000239	CcSEcCtD
Treprostinil—Headache—Gabapentin—epilepsy syndrome	8.16e-05	0.000237	CcSEcCtD
Treprostinil—Asthenia—Topiramate—epilepsy syndrome	7.86e-05	0.000229	CcSEcCtD
Treprostinil—Pruritus—Topiramate—epilepsy syndrome	7.75e-05	0.000226	CcSEcCtD
Treprostinil—Nausea—Gabapentin—epilepsy syndrome	7.73e-05	0.000225	CcSEcCtD
Treprostinil—Diarrhoea—Topiramate—epilepsy syndrome	7.49e-05	0.000218	CcSEcCtD
Treprostinil—Dizziness—Topiramate—epilepsy syndrome	7.24e-05	0.000211	CcSEcCtD
Treprostinil—Vomiting—Topiramate—epilepsy syndrome	6.96e-05	0.000203	CcSEcCtD
Treprostinil—Rash—Topiramate—epilepsy syndrome	6.91e-05	0.000201	CcSEcCtD
Treprostinil—Dermatitis—Topiramate—epilepsy syndrome	6.9e-05	0.000201	CcSEcCtD
Treprostinil—Headache—Topiramate—epilepsy syndrome	6.86e-05	0.0002	CcSEcCtD
Treprostinil—Nausea—Topiramate—epilepsy syndrome	6.51e-05	0.000189	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—CX3CR1—epilepsy syndrome	5.53e-05	0.000321	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HRH3—epilepsy syndrome	5.49e-05	0.000319	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	5.49e-05	0.000319	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—BDKRB1—epilepsy syndrome	5.42e-05	0.000315	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CX3CL1—epilepsy syndrome	5.42e-05	0.000315	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CHRM2—epilepsy syndrome	5.42e-05	0.000315	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ALB—epilepsy syndrome	5.41e-05	0.000314	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.41e-05	0.000314	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—OPRM1—epilepsy syndrome	5.41e-05	0.000314	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CYP2D6—epilepsy syndrome	5.39e-05	0.000313	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CDC42—epilepsy syndrome	5.3e-05	0.000307	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GABBR1—epilepsy syndrome	5.27e-05	0.000306	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CCR5—epilepsy syndrome	5.22e-05	0.000303	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ADRA2A—epilepsy syndrome	5.14e-05	0.000298	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AVP—epilepsy syndrome	5.13e-05	0.000297	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—BCHE—epilepsy syndrome	5.11e-05	0.000297	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR3—epilepsy syndrome	5.11e-05	0.000296	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—HTR2A—epilepsy syndrome	5.1e-05	0.000296	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HRH3—epilepsy syndrome	5.06e-05	0.000293	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	5.02e-05	0.000291	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—SIRT1—epilepsy syndrome	5.02e-05	0.000291	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	4.99e-05	0.000289	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NPY—epilepsy syndrome	4.98e-05	0.000289	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ATP2A2—epilepsy syndrome	4.98e-05	0.000289	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—OPRM1—epilepsy syndrome	4.98e-05	0.000289	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—VDR—epilepsy syndrome	4.94e-05	0.000287	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—SLC2A1—epilepsy syndrome	4.88e-05	0.000283	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AGT—epilepsy syndrome	4.84e-05	0.000281	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CA13—epilepsy syndrome	4.84e-05	0.000281	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PLCB1—epilepsy syndrome	4.83e-05	0.00028	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—TH—epilepsy syndrome	4.81e-05	0.000279	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CRH—epilepsy syndrome	4.8e-05	0.000279	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL2—epilepsy syndrome	4.8e-05	0.000279	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL3—epilepsy syndrome	4.8e-05	0.000279	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—OXT—epilepsy syndrome	4.8e-05	0.000279	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HSPB1—epilepsy syndrome	4.8e-05	0.000279	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CCR5—epilepsy syndrome	4.8e-05	0.000279	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCR5—epilepsy syndrome	4.74e-05	0.000275	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.73e-05	0.000275	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR3—epilepsy syndrome	4.7e-05	0.000273	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—HTR2A—epilepsy syndrome	4.7e-05	0.000273	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—H2AFX—epilepsy syndrome	4.69e-05	0.000272	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HTR2A—epilepsy syndrome	4.64e-05	0.000269	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NPY—epilepsy syndrome	4.58e-05	0.000266	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ATP2A2—epilepsy syndrome	4.58e-05	0.000266	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—YWHAZ—epilepsy syndrome	4.52e-05	0.000262	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.48e-05	0.00026	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTK2B—epilepsy syndrome	4.46e-05	0.000259	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TSC1—epilepsy syndrome	4.46e-05	0.000259	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AGT—epilepsy syndrome	4.46e-05	0.000259	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—NR3C1—epilepsy syndrome	4.45e-05	0.000258	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HSPB1—epilepsy syndrome	4.42e-05	0.000256	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CRH—epilepsy syndrome	4.42e-05	0.000256	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL3—epilepsy syndrome	4.42e-05	0.000256	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL2—epilepsy syndrome	4.42e-05	0.000256	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—OXT—epilepsy syndrome	4.42e-05	0.000256	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AGT—epilepsy syndrome	4.4e-05	0.000255	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCR5—epilepsy syndrome	4.36e-05	0.000253	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SST—epilepsy syndrome	4.34e-05	0.000252	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR2—epilepsy syndrome	4.34e-05	0.000252	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NTRK2—epilepsy syndrome	4.34e-05	0.000252	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—DUSP6—epilepsy syndrome	4.3e-05	0.00025	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HTR2A—epilepsy syndrome	4.27e-05	0.000248	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADRA2A—epilepsy syndrome	4.25e-05	0.000247	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PLAT—epilepsy syndrome	4.23e-05	0.000246	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SRC—epilepsy syndrome	4.16e-05	0.000241	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.12e-05	0.000239	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTK2B—epilepsy syndrome	4.11e-05	0.000238	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TSC1—epilepsy syndrome	4.11e-05	0.000238	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL12—epilepsy syndrome	4.08e-05	0.000237	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—BDKRB2—epilepsy syndrome	4.08e-05	0.000237	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—POMC—epilepsy syndrome	4.08e-05	0.000237	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PRKCB—epilepsy syndrome	4.06e-05	0.000236	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VEGFA—epilepsy syndrome	4.05e-05	0.000235	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AGT—epilepsy syndrome	4.05e-05	0.000235	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6ST—epilepsy syndrome	4.05e-05	0.000235	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—HMOX1—epilepsy syndrome	4.01e-05	0.000233	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JUNB—epilepsy syndrome	4.01e-05	0.000233	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CNR1—epilepsy syndrome	4.01e-05	0.000233	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR2—epilepsy syndrome	4e-05	0.000232	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SST—epilepsy syndrome	4e-05	0.000232	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NTRK2—epilepsy syndrome	4e-05	0.000232	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PLCB1—epilepsy syndrome	3.99e-05	0.000232	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—DUSP6—epilepsy syndrome	3.96e-05	0.00023	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CAT—epilepsy syndrome	3.96e-05	0.00023	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADRA2A—epilepsy syndrome	3.91e-05	0.000227	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HTR7—epilepsy syndrome	3.91e-05	0.000227	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PLAT—epilepsy syndrome	3.89e-05	0.000226	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	3.89e-05	0.000226	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ABCB1—epilepsy syndrome	3.85e-05	0.000223	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SRC—epilepsy syndrome	3.83e-05	0.000222	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HBEGF—epilepsy syndrome	3.8e-05	0.00022	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL12—epilepsy syndrome	3.76e-05	0.000218	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—BDKRB2—epilepsy syndrome	3.76e-05	0.000218	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—POMC—epilepsy syndrome	3.75e-05	0.000218	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PRKCB—epilepsy syndrome	3.74e-05	0.000217	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—epilepsy syndrome	3.73e-05	0.000216	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT3—epilepsy syndrome	3.73e-05	0.000216	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6ST—epilepsy syndrome	3.73e-05	0.000216	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—POMC—epilepsy syndrome	3.7e-05	0.000215	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JUNB—epilepsy syndrome	3.69e-05	0.000214	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CNR1—epilepsy syndrome	3.69e-05	0.000214	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PLCB1—epilepsy syndrome	3.67e-05	0.000213	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PDXK—epilepsy syndrome	3.67e-05	0.000213	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	3.67e-05	0.000213	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—FAR1—epilepsy syndrome	3.67e-05	0.000213	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ADK—epilepsy syndrome	3.67e-05	0.000213	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CERS1—epilepsy syndrome	3.67e-05	0.000213	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	3.67e-05	0.000213	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADAM10—epilepsy syndrome	3.64e-05	0.000211	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCL2—epilepsy syndrome	3.62e-05	0.00021	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HTR7—epilepsy syndrome	3.6e-05	0.000209	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GPX1—epilepsy syndrome	3.58e-05	0.000208	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HBEGF—epilepsy syndrome	3.49e-05	0.000203	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—S100B—epilepsy syndrome	3.44e-05	0.0002	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT3—epilepsy syndrome	3.43e-05	0.000199	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SOCS3—epilepsy syndrome	3.41e-05	0.000198	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—POMC—epilepsy syndrome	3.41e-05	0.000198	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDC42—epilepsy syndrome	3.4e-05	0.000197	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GAMT—epilepsy syndrome	3.35e-05	0.000195	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PNPO—epilepsy syndrome	3.35e-05	0.000195	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	3.35e-05	0.000195	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	3.35e-05	0.000195	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADAM10—epilepsy syndrome	3.35e-05	0.000194	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCL2—epilepsy syndrome	3.33e-05	0.000193	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AVP—epilepsy syndrome	3.29e-05	0.000191	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—S100B—epilepsy syndrome	3.17e-05	0.000184	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AGT—epilepsy syndrome	3.14e-05	0.000182	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SOCS3—epilepsy syndrome	3.14e-05	0.000182	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDC42—epilepsy syndrome	3.13e-05	0.000182	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CA4—epilepsy syndrome	3.12e-05	0.000181	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—QDPR—epilepsy syndrome	3.12e-05	0.000181	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HES1—epilepsy syndrome	3.11e-05	0.000181	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	3.11e-05	0.00018	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOE—epilepsy syndrome	3.08e-05	0.000179	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AVP—epilepsy syndrome	3.03e-05	0.000176	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FYN—epilepsy syndrome	3.03e-05	0.000176	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—H2AFX—epilepsy syndrome	3.02e-05	0.000175	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MEF2C—epilepsy syndrome	3.01e-05	0.000175	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—COX3—epilepsy syndrome	2.93e-05	0.00017	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—YWHAZ—epilepsy syndrome	2.91e-05	0.000169	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NGF—epilepsy syndrome	2.88e-05	0.000167	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HES1—epilepsy syndrome	2.86e-05	0.000166	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR5—epilepsy syndrome	2.8e-05	0.000162	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FYN—epilepsy syndrome	2.79e-05	0.000162	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	2.78e-05	0.000161	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PFKL—epilepsy syndrome	2.78e-05	0.000161	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	2.78e-05	0.000161	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	2.78e-05	0.000161	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	2.78e-05	0.000161	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—H2AFX—epilepsy syndrome	2.78e-05	0.000161	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MEF2C—epilepsy syndrome	2.77e-05	0.000161	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HTR2A—epilepsy syndrome	2.74e-05	0.000159	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	2.72e-05	0.000158	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.7e-05	0.000157	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—YWHAZ—epilepsy syndrome	2.68e-05	0.000155	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NGF—epilepsy syndrome	2.65e-05	0.000154	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—POMC—epilepsy syndrome	2.64e-05	0.000153	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TSC2—epilepsy syndrome	2.6e-05	0.000151	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AGT—epilepsy syndrome	2.6e-05	0.000151	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—AKT1—epilepsy syndrome	2.59e-05	0.00015	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR5—epilepsy syndrome	2.58e-05	0.000149	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOE—epilepsy syndrome	2.55e-05	0.000148	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NEU1—epilepsy syndrome	2.54e-05	0.000147	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ATIC—epilepsy syndrome	2.54e-05	0.000147	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—UPB1—epilepsy syndrome	2.54e-05	0.000147	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HTR2A—epilepsy syndrome	2.52e-05	0.000146	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KDR—epilepsy syndrome	2.49e-05	0.000145	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	2.45e-05	0.000142	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—epilepsy syndrome	2.41e-05	0.00014	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PRKCB—epilepsy syndrome	2.4e-05	0.000139	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TSC2—epilepsy syndrome	2.39e-05	0.000139	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AGT—epilepsy syndrome	2.39e-05	0.000139	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6ST—epilepsy syndrome	2.39e-05	0.000139	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—AKT1—epilepsy syndrome	2.38e-05	0.000138	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GBE1—epilepsy syndrome	2.36e-05	0.000137	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	2.36e-05	0.000137	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOE—epilepsy syndrome	2.34e-05	0.000136	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.31e-05	0.000134	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KDR—epilepsy syndrome	2.3e-05	0.000133	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	2.22e-05	0.000129	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PRKCB—epilepsy syndrome	2.21e-05	0.000128	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6ST—epilepsy syndrome	2.2e-05	0.000128	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—POMC—epilepsy syndrome	2.19e-05	0.000127	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	2.16e-05	0.000125	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL2—epilepsy syndrome	2.14e-05	0.000124	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—epilepsy syndrome	2.11e-05	0.000122	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NT5E—epilepsy syndrome	2.11e-05	0.000122	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALAD—epilepsy syndrome	2.11e-05	0.000122	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—POMC—epilepsy syndrome	2.01e-05	0.000117	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	2.01e-05	0.000117	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	2.01e-05	0.000117	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL2—epilepsy syndrome	1.97e-05	0.000114	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	1.97e-05	0.000114	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—FGF2—epilepsy syndrome	1.93e-05	0.000112	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ADSL—epilepsy syndrome	1.93e-05	0.000112	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1.89e-05	0.00011	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	1.85e-05	0.000108	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RELA—epilepsy syndrome	1.8e-05	0.000104	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FGF2—epilepsy syndrome	1.78e-05	0.000103	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MTOR—epilepsy syndrome	1.76e-05	0.000102	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	1.73e-05	0.000101	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AQP1—epilepsy syndrome	1.68e-05	9.77e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RELA—epilepsy syndrome	1.65e-05	9.59e-05	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AKT1—epilepsy syndrome	1.63e-05	9.48e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MTOR—epilepsy syndrome	1.62e-05	9.4e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CASP3—epilepsy syndrome	1.62e-05	9.4e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.62e-05	9.38e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—JUN—epilepsy syndrome	1.57e-05	9.13e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—epilepsy syndrome	1.53e-05	8.88e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.52e-05	8.83e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.52e-05	8.83e-05	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AKT1—epilepsy syndrome	1.5e-05	8.73e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CASP3—epilepsy syndrome	1.49e-05	8.65e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKT1—epilepsy syndrome	1.48e-05	8.61e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—JUN—epilepsy syndrome	1.45e-05	8.4e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.42e-05	8.23e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SRC—epilepsy syndrome	1.41e-05	8.19e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—epilepsy syndrome	1.41e-05	8.17e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.39e-05	8.06e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—epilepsy syndrome	1.37e-05	7.97e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AKT1—epilepsy syndrome	1.37e-05	7.92e-05	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—AKT1—epilepsy syndrome	1.36e-05	7.91e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SRC—epilepsy syndrome	1.3e-05	7.53e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—epilepsy syndrome	1.26e-05	7.34e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.24e-05	7.2e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.21e-05	7.02e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.2e-05	6.97e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.19e-05	6.92e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.09e-05	6.31e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.08e-05	6.29e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKT1—epilepsy syndrome	1.06e-05	6.15e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.03e-05	5.99e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.03e-05	5.97e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	9.81e-06	5.69e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	9.7e-06	5.63e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TH—epilepsy syndrome	9.67e-06	5.61e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.52e-06	5.52e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT1—epilepsy syndrome	8.77e-06	5.09e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	8.07e-06	4.68e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT1—epilepsy syndrome	8.07e-06	4.68e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CAT—epilepsy syndrome	7.96e-06	4.62e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	7.74e-06	4.49e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPX1—epilepsy syndrome	7.2e-06	4.18e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AGT—epilepsy syndrome	6.31e-06	3.66e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOE—epilepsy syndrome	6.19e-06	3.59e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—POMC—epilepsy syndrome	5.31e-06	3.08e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—epilepsy syndrome	4.84e-06	2.81e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	4.24e-06	2.46e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKT1—epilepsy syndrome	2.13e-06	1.24e-05	CbGpPWpGaD
